Document Detail


Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.
MedLine Citation:
PMID:  19386578     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment and prevention studies over the past decade have enrolled patients believed to be at risk for future psychosis. These patients were considered at risk for psychosis by virtue of meeting research criteria derived from retrospective accounts of the psychosis prodrome. This study evaluated the diagnostic validity of the prospective "prodromal risk syndrome" construct. Patients assessed by the Structured Interview for Prodromal Syndromes as meeting criteria of prodromal syndromes (n = 377) from the North American Prodrome Longitudinal Study were compared with normal comparison (NC, n = 196), help-seeking comparison (HSC, n = 198), familial high-risk (FHR, n = 40), and schizotypal personality disorder (SPD, n = 49) groups. Comparisons were made on variables from cross-sectional demographic, symptom, functional, comorbid diagnostic, and family history domains of assessment as well as on follow-up outcome. Prodromal risk syndrome patients as a group were robustly distinguished from NC subjects across all domains and distinguished from HSC subjects and from FHR subjects on most measures in many of these domains. Adolescent and young adult SPD patients, while distinct from prodromal patients on definitional grounds, were similar to prodromals on multiple measures, consistent with SPD in young patients possibly being an independent risk syndrome for psychosis. The strong evidence of diagnostic validity for the prodromal risk syndrome for first psychosis raises the question of its evaluation for inclusion in Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition).
Authors:
Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Related Documents :
2668648 - Differentiation induction therapy of myelodysplastic syndromes.
19095758 - Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longit...
1865418 - Rheumatic manifestations in myelodysplastic syndromes.
20337268 - Severe hypotony associated with parry-romberg syndrome.
17968208 - Rhabdomyolysis associated with compartment syndrome resulting in acute renal failure.
9619648 - Kleine-levin syndrome and parkinsonian symptoms--a case report.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-04-21
Journal Detail:
Title:  Schizophrenia bulletin     Volume:  35     ISSN:  1745-1701     ISO Abbreviation:  Schizophr Bull     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-19     Completed Date:  2009-11-16     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  0236760     Medline TA:  Schizophr Bull     Country:  United States    
Other Details:
Languages:  eng     Pagination:  894-908     Citation Subset:  IM    
Affiliation:
PRIME Prodromal Research Clinic, Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA. scott.woods@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Comorbidity
Disability Evaluation
Disease Progression
Early Diagnosis
Female
Humans
Longitudinal Studies
Male
Patient Acceptance of Health Care / psychology
Psychiatric Status Rating Scales / statistics & numerical data*
Psychometrics / statistics & numerical data
Psychotic Disorders / diagnosis*,  genetics,  psychology
Reproducibility of Results
Risk Assessment
Schizophrenia / diagnosis*
Schizophrenic Psychology*
Schizotypal Personality Disorder / diagnosis*,  genetics,  psychology
Social Adjustment
United States
Young Adult
Grant Support
ID/Acronym/Agency:
K05MH01654/MH/NIMH NIH HHS; K24 MH076191-05/MH/NIMH NIH HHS; K24 MH76191/MH/NIMH NIH HHS; P50 MH064065/MH/NIMH NIH HHS; P50 MH080272/MH/NIMH NIH HHS; R01 MH060720-10/MH/NIMH NIH HHS; R01 MH061523/MH/NIMH NIH HHS; R01 MH065079/MH/NIMH NIH HHS; R01 MH065562/MH/NIMH NIH HHS; R01 MH60720/MH/NIMH NIH HHS; R01MH062066/MH/NIMH NIH HHS; R21MH075027/MH/NIMH NIH HHS; U01 MH066069/MH/NIMH NIH HHS; U01 MH066134/MH/NIMH NIH HHS; U01 MH066160/MH/NIMH NIH HHS; U01 MH081944-05/MH/NIMH NIH HHS
Comments/Corrections
Comment In:
Schizophr Bull. 2009 Sep;35(5):841-3   [PMID:  19633215 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intrinsic motivation inventory: an adapted measure for schizophrenia research.
Next Document:  Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of fi...